Key result
Targeting CRYAB phosphorylation at serine 59, either genetically or with 25-hydroxycholesterol, attenuated protein aggregation and rescued post-myocardial infarction left ventricular systolic dysfunction in mice.
Why the study?
Protein aggregates are emerging therapeutic targets in rare cardiomyopathies, but their role in more prevalent heart-failure syndromes remains mechanistically unexamined.
Preventing CRYAB phosphorylation at serine 59 reduces protein aggregation and rescues left ventricular systolic dysfunction after myocardial infarction, highlighting condensatopathy as a therapeutic target in ischemic cardiomyopathy.
Protein aggregates are emerging therapeutic targets in rare monogenic causes of cardiomyopathy and amyloid heart disease, but their role in more prevalent heart-failure syndromes remains mechanistically unexamined. We observed mislocalization of desmin and sarcomeric proteins to aggregates in human myocardium with ischemic cardiomyopathy and in mouse hearts with post-myocardial infarction ventricular remodeling, mimicking findings of autosomal-dominant cardiomyopathy induced by the R120G mutation in the cognate chaperone protein CRYAB. In both syndromes, we demonstrate increased partitioning of CRYAB phosphorylated on serine 59 to NP40-insoluble aggregate-rich biochemical fraction. While CRYAB undergoes phase separation to form condensates, the phosphomimetic mutation of serine 59 to aspartate (S59D) in CRYAB mimics R120G-CRYAB mutants with reduced condensate fluidity, formation of protein aggregates, and increased cell death. Conversely, changing serine to alanine (phosphorylation-deficient mutation) at position 59 (S59A) restored condensate fluidity and reduced both R120G-CRYAB aggregates and cell death. In mice, S59D CRYAB knockin was sufficient to induce desmin mislocalization and myocardial protein aggregates, while S59A CRYAB knockin rescued left ventricular systolic dysfunction after myocardial infarction and preserved desmin localization with reduced myocardial protein aggregates. 25-Hydroxycholesterol attenuated CRYAB serine 59 phosphorylation and rescued post-myocardial infarction adverse remodeling. Thus, targeting CRYAB phosphorylation-induced condensatopathy is an attractive strategy to counter ischemic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2025) studied Ischemic cardiomyopathy. 25-Hydroxycholesterol and CRYAB S59A mutation vs. Vehicle / Wild-type was evaluated on Left ventricular systolic dysfunction and adverse remodeling after myocardial infarction. Targeting CRYAB phosphorylation at serine 59, either genetically or with 25-hydroxycholesterol, attenuated protein aggregation and rescued post-myocardial infarction left ventricular systolic dysfunction in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: